Literature DB >> 21178482

Antagonistic crosstalk between type I and II interferons and increased host susceptibility to bacterial infections.

Manira Rayamajhi1, Jessica Humann, Staci Kearney, Krista K Hill, Laurel L Lenz.   

Abstract

Type I and II interferons (IFNs αβ and γ) have opposing effects on immune resistance to certain pathogenic bacteria. While IFNγ generally plays a protective role, IFNαβ exacerbates Listeria monocytogenes and Mycobacterium tuberculosis infections. Our findings provided evidence that this increased susceptibility reflects a novel antagonistic cross talk between IFNαβ and IFNγ. Macrophages infected with L. monocytogenes strains that induce IFNαβ production responded poorly to IFNγ, as measured by reduced phosphorylation of STAT1 and reduced IFNγ-dependent gene expression. The impaired responsiveness to IFNγ correlated with reduced expression of its receptor, IFNGR, by both infected and bystander macrophages. Down regulation of IFNGR was dependent on responsiveness to IFNγ and mimicked by recombinant IFNβ. Mice lacking responsiveness to IFNαβ (IFNAR1 (-/-)) retained high IFNGR expression, developed higher expression of MHC-II on macrophages and DCs, and were more resistant to systemic L. monocytogenes infection--but only in the presence of IFNγ. Thus, the ability of IFNαβ to down regulate IFNGR provides an explanation for its ability to reduce responsiveness to IFNγ and to increase host susceptibility to bacterial infection. It remains to be determined whether and how such antagonistic interferon crosstalk benefits the host.

Entities:  

Keywords:  Listeria monocytogenes; Mycobacterium tuberculosis; bacterial pathogens; cytokine receptor; gene expression; immune suppression; interferons; macrophage activation

Mesh:

Substances:

Year:  2010        PMID: 21178482      PMCID: PMC2957886          DOI: 10.4161/viru.1.5.12787

Source DB:  PubMed          Journal:  Virulence        ISSN: 2150-5594            Impact factor:   5.882


  42 in total

1.  Targeted disruption of the interferon-gamma receptor 2 gene results in severe immune defects in mice.

Authors:  B Lu; C Ebensperger; Z Dembic; Y Wang; M Kvatyuk; T Lu; R L Coffman; S Pestka; P B Rothman
Journal:  Proc Natl Acad Sci U S A       Date:  1998-07-07       Impact factor: 11.205

2.  Interferon-gamma-receptor deficiency in an infant with fatal bacille Calmette-Guérin infection.

Authors:  E Jouanguy; F Altare; S Lamhamedi; P Revy; J F Emile; M Newport; M Levin; S Blanche; E Seboun; A Fischer; J L Casanova
Journal:  N Engl J Med       Date:  1996-12-26       Impact factor: 91.245

3.  Induction of macrophage Ia antigen expression by rIFN-gamma and down-regulation by IFN-alpha/beta and dexamethasone are regulated transcriptionally.

Authors:  D Fertsch-Ruggio; D R Schoenberg; S N Vogel
Journal:  J Immunol       Date:  1988-09-01       Impact factor: 5.422

4.  A mutation in the interferon-gamma-receptor gene and susceptibility to mycobacterial infection.

Authors:  M J Newport; C M Huxley; S Huston; C M Hawrylowicz; B A Oostra; R Williamson; M Levin
Journal:  N Engl J Med       Date:  1996-12-26       Impact factor: 91.245

5.  Polymorphism within the interferon-gamma/receptor complex is associated with pulmonary tuberculosis.

Authors:  Graham S Cooke; Sarah J Campbell; Jackson Sillah; Per Gustafson; Boubacar Bah; Georgio Sirugo; Steve Bennett; Keith P W J McAdam; Oumou Sow; Christian Lienhardt; Adrian V S Hill
Journal:  Am J Respir Crit Care Med       Date:  2006-05-11       Impact factor: 21.405

6.  Immune response in mice that lack the interferon-gamma receptor.

Authors:  S Huang; W Hendriks; A Althage; S Hemmi; H Bluethmann; R Kamijo; J Vilcek; R M Zinkernagel; M Aguet
Journal:  Science       Date:  1993-03-19       Impact factor: 47.728

7.  Mutation in the signal-transducing chain of the interferon-gamma receptor and susceptibility to mycobacterial infection.

Authors:  S E Dorman; S M Holland
Journal:  J Clin Invest       Date:  1998-06-01       Impact factor: 14.808

8.  Crucial role of interferon consensus sequence binding protein, but neither of interferon regulatory factor 1 nor of nitric oxide synthesis for protection against murine listeriosis.

Authors:  T Fehr; G Schoedon; B Odermatt; T Holtschke; M Schneemann; M F Bachmann; T W Mak; I Horak; R M Zinkernagel
Journal:  J Exp Med       Date:  1997-03-03       Impact factor: 14.307

9.  Disseminated tuberculosis in interferon gamma gene-disrupted mice.

Authors:  A M Cooper; D K Dalton; T A Stewart; J P Griffin; D G Russell; I M Orme
Journal:  J Exp Med       Date:  1993-12-01       Impact factor: 14.307

10.  An essential role for interferon gamma in resistance to Mycobacterium tuberculosis infection.

Authors:  J L Flynn; J Chan; K J Triebold; D K Dalton; T A Stewart; B R Bloom
Journal:  J Exp Med       Date:  1993-12-01       Impact factor: 14.307

View more
  38 in total

1.  Beneficial innate signaling interference for antibacterial responses by a Toll-like receptor-mediated enhancement of the MKP-IRF3 axis.

Authors:  Hideo Negishi; Kosuke Matsuki; Nobuyasu Endo; Hana Sarashina; Shoji Miki; Atsushi Matsuda; Keiko Fukazawa; Naoko Taguchi-Atarashi; Hiroaki Ikushima; Hideyuki Yanai; Junko Nishio; Kenya Honda; Yoichiro Fujioka; Yusuke Ohba; Tetsuo Noda; Shun'ichiro Taniguchi; Eisuke Nishida; Yongliang Zhang; Hongbo Chi; Richard A Flavell; Tadatsugu Taniguchi
Journal:  Proc Natl Acad Sci U S A       Date:  2013-11-18       Impact factor: 11.205

2.  MPYS is required for IFN response factor 3 activation and type I IFN production in the response of cultured phagocytes to bacterial second messengers cyclic-di-AMP and cyclic-di-GMP.

Authors:  Lei Jin; Krista K Hill; Holly Filak; Jennifer Mogan; Heather Knowles; Bicheng Zhang; Anne-Laure Perraud; John C Cambier; Laurel L Lenz
Journal:  J Immunol       Date:  2011-08-03       Impact factor: 5.422

Review 3.  The price of immunity.

Authors:  Romina S Goldszmid; Giorgio Trinchieri
Journal:  Nat Immunol       Date:  2012-09-18       Impact factor: 25.606

4.  Type I interferons induced by radiation therapy mediate recruitment and effector function of CD8(+) T cells.

Authors:  Joanne Y H Lim; Scott A Gerber; Shawn P Murphy; Edith M Lord
Journal:  Cancer Immunol Immunother       Date:  2013-12-20       Impact factor: 6.968

5.  The Histone Methyltransferase Setdb2 Modulates Macrophage Phenotype and Uric Acid Production in Diabetic Wound Repair.

Authors:  Andrew S Kimball; Frank M Davis; Aaron denDekker; Amrita D Joshi; Matthew A Schaller; Jennifer Bermick; Xianying Xing; Charles F Burant; Andrea T Obi; Dylan Nysz; Scott Robinson; Ron Allen; Nicholas W Lukacs; Peter K Henke; Johann E Gudjonsson; Bethany B Moore; Steve L Kunkel; Katherine A Gallagher
Journal:  Immunity       Date:  2019-07-23       Impact factor: 31.745

6.  Innate and adaptive interferons suppress IL-1α and IL-1β production by distinct pulmonary myeloid subsets during Mycobacterium tuberculosis infection.

Authors:  Katrin D Mayer-Barber; Bruno B Andrade; Daniel L Barber; Sara Hieny; Carl G Feng; Patricia Caspar; Sandy Oland; Siamon Gordon; Alan Sher
Journal:  Immunity       Date:  2011-12-23       Impact factor: 31.745

Review 7.  Effects of type I interferons in malaria.

Authors:  Ismail Sebina; Ashraful Haque
Journal:  Immunology       Date:  2018-07-05       Impact factor: 7.397

8.  Host-directed therapy of tuberculosis based on interleukin-1 and type I interferon crosstalk.

Authors:  Katrin D Mayer-Barber; Bruno B Andrade; Sandra D Oland; Eduardo P Amaral; Daniel L Barber; Jacqueline Gonzales; Steven C Derrick; Ruiru Shi; Nathella Pavan Kumar; Wang Wei; Xing Yuan; Guolong Zhang; Ying Cai; Subash Babu; Marta Catalfamo; Andres M Salazar; Laura E Via; Clifton E Barry; Alan Sher
Journal:  Nature       Date:  2014-06-25       Impact factor: 49.962

Review 9.  Innate immune function by Toll-like receptors: distinct responses in newborns and the elderly.

Authors:  Tobias R Kollmann; Ofer Levy; Ruth R Montgomery; Stanislas Goriely
Journal:  Immunity       Date:  2012-11-16       Impact factor: 31.745

Review 10.  Differential effects of type I and II interferons on myeloid cells and resistance to intracellular bacterial infections.

Authors:  Staci Kearney; Christine Delgado; Laurel L Lenz
Journal:  Immunol Res       Date:  2013-03       Impact factor: 2.829

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.